GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Cyclically Adjusted Price-to-FCF

Samsung BioLogics Co (XKRX:207940) Cyclically Adjusted Price-to-FCF : (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Samsung BioLogics Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Cyclically Adjusted Price-to-FCF Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Samsung BioLogics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF falls into.



Samsung BioLogics Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Samsung BioLogics Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Samsung BioLogics Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=7880.962/118.8477*118.8477
=7,880.962

Current CPI (Dec23) = 118.8477.

Samsung BioLogics Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -39,728.583 99.098 -47,646.277
201512 -13,175.485 100.220 -15,624.387
201612 -4,023.720 101.560 -4,708.644
201712 -5,310.175 102.990 -6,127.800
201812 -4,747.661 104.350 -5,407.270
201912 -2,558.258 105.120 -2,892.343
202012 800.443 105.765 899.451
202112 500.193 109.676 542.020
202212 -804.736 115.200 -830.216
202312 7,880.962 118.848 7,880.962

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Samsung BioLogics Co  (XKRX:207940) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Samsung BioLogics Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co (XKRX:207940) Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines